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"OVER-EXPRESSION" PROTEIN-I Y-BOX IKATAN MANUSIA-
PERBANDINGAN SISTEM PENGEKSPRESAN ANTARA MAMALIA 
DAN BAKTERIA 
ABSTRAK 
Protein "Y -Box I" man usia (YB-1) merupakan sejenis protein yang terlibat dalam 
pengendalian transkripsi dan translasi dalam rangkaian gen yang besar. YB-1 melibatkan 
regulasi fungsi sel yang berbagai-bagai. Kajian dahulu menunjukkan pengekspresan YB-1 
ditingkatkan dalam banyak kes kanser dan menunjukan hubungan yang rapat dengan 
prognosis kanser serta memberi rintangan terhadap ubat kanser. Bagi lebih memahami dan 
mendalami peranan YB-1 dalam regulasi transkripsi and translasi perkembangan barah dan 
kanser, satu ujian "over-expression" telah dilakukan. Dua plasmid gabungan yang berbeza, 
pGEX-2TK-YB-1 and pREP-YB-1 telah digunakan bagi melakukan ujian "over-
expression" dalam bakteria (Escherichia coli, BL-21) dan sistem mamalia (sel-sel HeLa). 
Perbandingan telah dilakukan dengan "Blot Western" menggunakan antibody poliklonal a 
YB-1. Keputusan "over-expression" menunjukan perbezaan pergerakan protein YB-1 
dalam sistem pengekspresan bakteria dan mamalia jika dibandingkan dengan saiz nilai 
teorinya. Sementara itu, ujian "over-expression" melibatkan transfeksi pREP-YB-1 ke 
dalam sel-sel HeLa dengan menggunakan kaedah transfeksi kalsium fosfat. Disebabkan 
kekurangan hasil, dan kurangnya kajian kuantitatif terhadap mekanisma dalam transfeksi 
kalsium fosfat, pengenalpastian masalah telah dilakukan dan langkah optima telah 
dicadangkan dalam perbincangan kajian ini. 
xii 
OVER-EXPRESSION OF HUMAN Y-BOX BINDING PROTEIN-I: A 
COMPARISON BETWEEN MAMMALIAN AND BACTERIAL 
EXPRESSION SYSTEM 
ABSTRACT 
The human Y -box protein I (YB- I) is a class of proteins involved in transcriptional 
and translational regulation of a wide range of genes. YB-1 is implicated in regulation of 
multiple cellular functions. Previous studies found that the YB-1 expression is upregulated 
in many tumours and is highly correlated with adverse cancer prognosis and resistance to 
cancer drugs. In order to further explore and understand the role of YB-1 in terms of 
transcriptional and translational regulation in development of malignancy tumours, an over-
expression assay has been carried out. Two different recombinants YB- I plasmid, pGEX-
2TK-YB-1 and pREP-YB-1 were used to carry out over-expression assay in bacterial 
(Escherichia coli, BL-21) and mammalian system (He La cancer cells) respectively. The 
comparison was analyzed by western blot analysis using a YB-1 polyclonal antibody. The 
over-expression results show a different migration of YB-1 protein in bacterial and 
mammalian expression system compared to their actual theoretical size. Meanwhile, over-
expression assay involved transfection of pREP-YB-1 into He La cells using calcium 
phosphate transfection method. Due to poor reproducibility and rare quantitative studies on 
the mechanisms of the calcium phosphate transfection, trouble shooting was done and the 
optimization steps were suggested in the discussion of this research. 
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1.0 LITERATURE REVIEW 
1.1 Calcium Phosphate Transfection 
The introduction of desirable genetic sequences into mammalian cells is an essential 
tool for analysis of gene structure. Transfection, the introduction of functional foreign DNA 
into the cell nucleus with the aim of repairing missing cell function and to provide means to 
enhance or silence gene expression is currently used extensively in the laboratory and is 
fast becoming a therapeutic reality. Viral infection is the oldest method for gene transfer, 
which was first demonstrated on Salmonella in 1952 (Zinder and Lederberg, 1952). The 
ability to introduce nucleic acids into ceJJs has enabled the advancement of our knowledge 
of genetic regulation and protein function within eukaryotic cells, tissues and organisms. 
For gene transfer into ceJJs, different viral vectors based on retroviruses, adenoviruses and 
other viruses were used. It is the most efficient method for transfering of DNA into cells, 
but it has serious drawbacks such as the risk of recombination, strong immunogenicity and 
carcinogenity (Burand et al., 1980; Crystal, 1995; Tripathy eta/., 1996). 
Progress in transfection technology was relatively slow until the advent of 
molecular biology techniques for cloning plasmid DNA. These techniques provided the 
means to prepare and manipulate DNA sequences and the ability to prepare virtually 
unlimited amounts of relatively pure DNA for transfection experiments. Cloned sequences 
could also be used to generate RNA in vitro with phage RNA polymerase using DNA 
templates with the corresponding polymerase promoter (Melton eta/., 1984). As the ability 
to prepare DNA and RNA for transfection became easier, additional methods, such as 
electroporation (Wong and Neumann, 1982), liposome-mediated transfer (Fraley at el., 
1980), polymeric [for example dendrimers (Haensler and Szoka, I 993) and poly 
ethylenimine (Godbey et a/., 1999)] and inorganic vectors (Chowdhury and Akaike, 2005) 
were developed to enable more efficient transfer of the nucleic acids to a broad range of 
cultured mammalian cells. 
Out of the latter group, calcium phosphate is by far the most widely used and 
studied biomaterial because it can transfect a wide variety of mammal ian cells in vitro 
(Jordan et a!., 1996) and avoids issues such as immune responses (Crystal, 1995) and high 
toxicity associated with other techniques (Kim et a/., 2005). Besides that, an in situ 
precipitation of the inorganic salt in the presence of DNA gives nano-particles which cells 
can immediately take up (Graham and van der Eb 1973a). The method is very easy and 
inexpensive, but the transfection efficiency is inferior to commercially available 
transfection agents, which are based on liposomes (Ishii et a/., 1997) and polymers (Tang et 
a/., 1996). 
Calcium phosphate transfection utilizes the basic procedure of Graham and van der 
Eb (I 973b ). The basic feature of this procedure include mixture of DNA with calcium 
chloride and sodium phosphate in buffered saline, formation of calcium phosphate-DNA 
complex, and incubation with cultured cells. After removal of the DNA containing 
medium, a brief incubation with dimethyl sulfoxide or glycerol is usually employed to 
enhance DNA uptake (Graham and van der Eb, 1 973a). 
2 
For most research involving transfection, the transfected gene is only transiently 
expressed. The DNA introduced in the transfection process is usually not inserted into the 
nuclear genome, the foreign DNA is lost at the later stage when the cells undergo mitosis. 
Meanwhile for stable transfection, the transfected gene actually remains in the genome of 
the cell and its daughter cells. To accomplish this, another gene is co-transfected, which 
gives the ceJI some selection advantage, such as resistance towards a certain toxin. Some of 
the transfected cells will, by chance, have inserted the foreign genetic material into their 
genome. If the toxin, towards which the co-transfected gene offers resistance, is then added 
to the cell culture, only those few cells with the foreign genes inserted into their genome 
will be able to proliferate, while other cells will die. After applying this selection pressure 
for some time, only the cells with a stable transfection remain and can be cultivated further. 
A reporter gene or plasmid is needed in order to observe the successful of 
transfection. In 1982, Gorman et a/. ( 1982) initiated the reporter gene concept with the 
bacterial chloramphenicol acetyltransferase (CAT) gene and associated CAT assay system 
(Gorman et a!., 1982). By using a reporter gene that is not endogenous to the cell coupled 
with a sensitive assay system for that gene product, it allows researcher to clone regulatory 
sequences of interest upstream of the reporter gene to study expression of the reporter gene 
under various conditions. Nowadays a common reporter gene is GFP (green fluorescent 
protein}, which is a powerful "tool" to express the protein in small sets of specific cells. 
This allows researchers to optically detect specific types of cells in vitro (in a dish), or even 
in vivo (in the living organism). 
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1.2 Transformation 
Transformation involved transfer of genetic information between bacteria by means 
of "naked" intracellular DNA fragments derived from bacterial donor cells and 
incorporated into a competent recipient cell. Transformation was first demonstrated in 1928 
by Frederick Griffith, an English bacteriologist searching for a vaccine against bacterial 
pneumonia. Griffith discovered that a non-virulent strain of Streptococcus pneumoniae 
could be transformed into a virulent one by exposure to strains of virulent S. pneumoniae 
that had been killed with heat. Meanwhile, transformation of E. coli was first described by 
Mandel and Higa (1970). Subsequent modifications to improve transformation efficiencies 
have included prolonged exposure of cells to calcium chloride (Dagert and Ehrlich, 1979), 
substitution of calcium with other cations such as Mn2+, and K+, and addition of other 
compounds such as dimethyl sulfoxide, dithiothreitol, and cobalt hexammine chloride 
(Hanahan, 1983). 
Transformation is always involved with the uptake of DNA by a competent 
recipient cell. Competence refers to the state of being able to take up exogenous DNA from 
the environment in transformation. Two different forms of competence should be 
distinguished: natural and artificial. Natural competence involve bacteria which naturally 
capable of taking up DNA under laboratory conditions; many more may be able to take it 
up in their natural environments. Such species carry sets of genes specifying machinery for 
bringing DNA across the cell membrane or membranes (Chen and Dubnau, 2004). 
Meanwhile, artificial competence is not encoded in the cell genes. Instead it is induced by 
laboratory procedures in which cells are passively made permeable to DNA, using 
conditions that do not normally occur in nature (Chen and Dubnau, 2004). 
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1.3 HeLa cancer cells 
A HeLa cell (also Hela or hela cell) is an immortal cell line used in medical 
research. The cell line was derived from cervical cancer cells taken from Henrietta Lacks, 
who died from her cancer on October 4, 1951. Henrietta's cells, named HeLa after the first 
letters in Henrietta and Lack. It became the first human cells to live indefinitely outside the 
body. HeLa cells helped researchers understand the differences between cancerous and 
normal cells, and quickly became a standard laboratory tool for studying the effects of 
radiation, growing viruses and testing medications. HeLa is still one of the most widely 
used cell lines (Skloot, 200 I). 
1.4 Glutathione-S-Transferase (GST) gene fusion system 
GST expression system was originally established to overcome problems with 
coupling, purification and detection of proteins. This system employs a pGEX vector 
(Figure 1.1 ), a vector based on the original pSj5 plasmid, which directs the synthesis of 
foreign proteins in E. coli as a fusion with the C domain of Shcistosoma japonicum 26 (Sj 
26) protein, a 26 kDa Glutathione S transferase (GST) (Smith and Johnson, 1988). 
Expression of all pGEX vector series is under the control of IPTG inducible trp-lac (tac) 
promoter (Smith and Johnson, 1988). 
The first pGEX vector ever developed was pGEX-1, which contains: tac promoter 
(Amann eta/., 1983; De Boer et a/., 1983) followed by the complete coding sequence of 
Sj26 (Smith eta/., 1986), in which the normal termination codon is replaced by a polylinker 
containing a unique recognition site for Bam HI, Sma I and Eco RJ, and followed by TGA 
translation termination codons in all three reading frames. There are I 0 different pGEX 
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pGEX vectors available at present (Amersham-Pharmacia Biotech Inc, USA) and all of 
them contain the reading frame at different location in relation to multiple cloning site to 
allow introduction of specific sequences such as sites for protein cleavage with Factor Xa 
(pGEX-3X, pGEX-SX-1 , pGEX-5X2, pGEX-5X3) or thrombin (pGEX-2T, pGEX-2TK). 
pGEX-2T {27-48011-01) 
Thrombin 
l t.eu Val Pro Arql Glv Ser I Pro G lie His Arl! ASQ 
GTG GIT CCG CGT GG"A TCG GGG ATI G T GGT GAG TGA CTG P.CG 
BamH S;na I EcoR I ----siop codoM 
pGEX-2TK (27-4587-01) 
Thrombin Kinase 
I Leu Val Pro .Arg! Giy SeriiArg Aig Ala Ser vad 
GTG GIT CCG GGT GGA TCT CGT CGT GCA TCT GIT, GGA Tf' CCG 9¥- ATT <;AT CGT GAC TGA 






Figure 1.1: Schematic diagram of parental vector pGEX series used in this research 
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2.0 INTRODUCTION 
2.1 Y -box binding protein 1, YB-1 
The human Y -box protein I (YB- I) is a member of the Y -box protein family, a 
class of proteins involved in transcriptional and translational regulation of a wide range of 
genes. Proteins of this family are active as transcriptional and translational regulators for 
messenger RNA and for a wide range of genes that contain the Y -box sequence (50-
CTGA TTGGCCAA-30) in their promoters (Ladomery, I 997). The name Y -box protein 
comes from the ability of the cold shock domain (CSD) to bind to the Y -box sequence [5'-
CTGA TTGG - 3 '] of DNA, which is an inverted CCAA T box, in the promoter region of 
many genes (Wolffe, 1994). The human YB-1 eDNA was first isolated by screening a 
human lymphoblastoid cell eDNA library expressed in Escherichia coli with an 
oligodeoxynucleotide containing the Y -box sequence (Didier et a/., I 988). Subsequently, 
additional Y -box binding proteins have been identified in human, frog (Tafuri and Wolffe, 
1990), rat (Ozer et a/., 1990), mouse (Tafuri eta/., 1993), and chicken (Grant and Deeley, 
1993). Examples of other proteins from this family are given in Table 2.1. 
The Y -box protein family contains three domains: N-terminaJ domain, cold shock 
domain and C-terminal domain. The highly conserved 70 amino acid DNA domain, the so 
caJled 'cold shock domain' CSD was defined initiaJJy in bacteria as a characteristic feature 
of this family (Wolffe et a/., 1992). Several eukaryotic genes, including those encoding 
major histocompatibility complex class II antigens, thymidine kinase, proliferating cell 
nuclear antigen, DNA polymerase a, epidermal growth factor receptor, DNA topoisomerase 
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lla, and multi drug resistance 1 protein (MDR 1) contain a Y -box in their regulatory regions 
(Ladomery and Sommerville, 1995; Wolffe, 1994; Wolffe et al., 1992). 
Table 2.1: Proposed functions for Y -Box proteins in different organisms 
Organism Protein Proposed function Reference 
Man YB-1 Transcriptional repressor (Didier et al., 1988; 
DNA repair Hasegawa et al., 
1991) 
Rat EF1 Transcription activator (Ozer et al., 1990) 
Mouse NSEPI Chromatin structural protein/ss (Gai et al., 1992; 
DNA recognition Kolluri et al., 1992; 
MUSYBl Transcriptional activator Tafuri eta/., 1993) 
MSYI Translational masking 
protein/general mRNA 
packaging 
Xenopus FRGY2 Transcriptional activator (Tafuri and Wolffe, 
Translational masking 1990; Tafuri and 
protein/general mRNA Wolffe, 1992) 
MRNAP4 packaging 
YB3 Translational repressor (Cohen and 
FRGY1 Transcriptional activator Reynolds, 1991; 
Transcriptional activator Murray et al., 1992; 
Tafuri and Wolffe, 
1990) 
E. coli CS7.4 Transcriptional activator (cold (La Teana et al., 
shock stress) 1991) 
B. subtilis CspB Cold shock response (Willimsky et al., 
1992) 
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The Y -box proteins were first identified and isolated by binding to a DNA probe 
containing the Y -box sequence (Dorn et al., I 987). It has been demonstrated that binding of 
the Y -box proteins to the intact Y -box sequence involves specific interactions (Didier et al., 
I 988). Subsequent binding studies have shown that the Y -box proteins can bind to a whole 
range of nucleic acids; namely, single-stranded DNA (ssDNA), RNA, damaged DNA, 
RNA and even triple-stranded DNA (Horwitz eta/., 1994; Koike eta/., 1997). Although no 
consistent picture emerged from the different binding studies, it appears that Y -box proteins 
have a preference for binding ssDNA, especially when it contains the Y -box sequence, 
evidence exists that Y -box proteins have a preference for binding pyrimidine rich DNA 
sequences (Wolffe, I 994). 
Apart from its role in transcription, YB-1 is a multifunctional protein that affects 
splicing, translational control, and repair of damaged DNA by interacting with several 
repair proteins (Gaudreault et a/., 2004; Kohno et al., 2003). Sakura et a/. (1988) further 
isolated two homologues of this gene, dbpA and dbpB, from human placental eDNA 
expression libraries using the c-erb2 gene promoter as the probe. Sequence analysis 
revealed that dbpB was identical to the YB-1. Kudo et a/. (I 995) isolated two clones 
identical to dbpA and dbpB (YB-1) eDNA after screening a A.-phage expression library 
with a DNA probe containing the human leukosialin CD43 promoter sequence which were 
found to have expression pattern are not restricted to only hematopoietic cells. The dbpA 
was located on the chromosome 12p 13 (Kudo et a/., 1995) and dbpB on chromosome I p34 
(Makino et a/., 1996). The dbpA is expressed in skeletal and heart muscles and the dbpB 
(YB-1) is found in skeletal muscle, kidney, lung and liver cells (Kudo eta/., 1995). YB-1 
protein is mainly located in the cytoplasm of the cell lines (Koike eta/., 1997). Interestingly 
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it was detected in both the cytoplasm and nucleus in various types of human cancers (Ohga 
eta/., 1996). 
2.1.1 dbpA :organization, structure and function 
All Y -Box proteins contain three domains: the N terminal domain, CSD and C 
terminal domain. The dbpA gene (Figure 2.1) consists of 10 exons spanning 24 kb of the 
genomic DNA (Kudo eta/., 1995). Its N terminal domain is encoded by the first exon, the 
CSD is encoded by the 2"d to the 5th exon and the C terminal domain by the 5th to gth exons 
(Figure 2.1 ). However, the exon sequences of theN terminal domain of dbpA are found to 
have only 15% homology with the dbpB's (YB-1) N-terminal domain, whereas its C 
terminal has 30o/o homology compared to CSD, which shows 96% sequence homology with 
its YB-1 counterpart (Toh et a/., 1998). 
Despite the significant differences between the N terminal domain and the C 
terminal domain of YB-1 and the dbpA protein, the dbpA protein binds to the consensus 5' 
- CTGA TTGG-3' Y -Box element since the binding occurs via the highly conserved CSD 
domain. The dbpA in HeLa cells is localized mostly in the cytoplasm, especially in 
perinuclear region (Kudo et a/., 1 995). However, despite extensive biochemical and 
structural characterization of dbpA, the function of this protein is still not clear (Kudo et al., 
1995). 
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N-terminal domain C-tenninal domain 
ATG TAA 
open reading frame 
Ex on 2 3 4 5 6 7 8 9 10 
Figure 2.1: Domain structure of human dbpA. Light and dark shading represent non-coding sequences and 
the cold shock domains (CSD), respectively. Adapted from Toh eta/., ( 1998) 
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